News

Recursion: Lack Of Near-Term Catalysts Leaves The Stock Vulnerable
Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...
Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...